Tim HuntCEO at Alliance for Regenerative Medicine
Profile
Tim joined ARM as CEO in 2022 with more than 20 years of experience in the biotechnology industry. A company-builder with a focus on corporate culture, he has helped early-stage organizations create internal cohesion and advance strategic initiatives. As chief executive, Tim divides his time between managing ARM and its global staff of nearly 30 employees and serving as an external advocate on behalf of ARM’s membership and the broader cell and gene therapy sector.
Agenda Sessions
Keynote: State of the Industry and Future Perspectives for Cell and Gene Therapies
, 8:00amView Session